 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Cellzome Uses New, High-Throughput Kinobeads Platform to Develop Inhibitor for PI3K Isoform
May 04, 2012
Cellzome Uses New, High-Throughput Kinobeads Platform to Develop Inhibitor for PI3K Isoform
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Proteomic Screen IDs Potential Use for GlaxoSmithKline Inhibitor in Treating Leukemia
October 7, 2011 / ProteoMonitor - GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
May 18, 2012 / ProteoMonitor - Scripps Team Develops Probe for Proteome-Wide Profiling of Cholesterol-Binding Proteins
February 15, 2013 / ProteoMonitor - Yeast Study Highlights Differences and Linkages Between Transcriptomic and Proteomic Regulation
November 2, 2012 / ProteoMonitor - CRC Study IDs Extensive Proteome Changes Between Healthy and Tumor Tissue but Few in Metastases
September 21, 2012 / ProteoMonitor